Diagnostic Co. Agrees To Oversight Reforms In Derivative Suit
By Sydney Price · December 10, 2025, 7:01 PM EST
A California federal judge has granted preliminary approval to a deal ending shareholder derivative claims that diagnostics company CareDx's executives and directors damaged the company by concealing its scheme to inflate...
To view the full article, register now.